TIZANIDINE

TIZANIDINE was reported 24114 times

These side effects are most commonly reported by patients taking TIZANIDINE:

# Side effect Count
0 FATIGUE 1758
1 PAIN 1661
2 NAUSEA 1642
3 DRUG INEFFECTIVE 1638
4 HEADACHE 1370
5 FALL 1355
6 DIARRHOEA 1156
7 CHRONIC KIDNEY DISEASE 1116
8 OFF LABEL USE 1058
9 DIZZINESS 1041
10 VOMITING 869
11 ARTHRALGIA 856
12 ACUTE KIDNEY INJURY 825
13 ANXIETY 811
14 ASTHENIA 811
15 DYSPNOEA 789
16 GAIT DISTURBANCE 777
17 URINARY TRACT INFECTION 759
18 MALAISE 740
19 PAIN IN EXTREMITY 731
20 BACK PAIN 730
21 MUSCLE SPASMS 730
22 DEPRESSION 727
23 RENAL FAILURE 707
24 SOMNOLENCE 672
25 INSOMNIA 655
26 PNEUMONIA 611
27 CONDITION AGGRAVATED 595
28 COMPLETED SUICIDE 580
29 PRURITUS 553
30 CONSTIPATION 552
31 FEELING ABNORMAL 551
32 MULTIPLE SCLEROSIS RELAPSE 550
33 RASH 544
34 DEATH 535
35 PRODUCT DOSE OMISSION ISSUE 532
36 MEMORY IMPAIRMENT 527
37 HYPOTENSION 516
38 COVID-19 515
39 WEIGHT DECREASED 515
40 HYPOAESTHESIA 514
41 HYPERTENSION 488
42 TREMOR 483
43 TOXICITY TO VARIOUS AGENTS 479
44 MUSCULAR WEAKNESS 468
45 MIGRAINE 464
46 DRUG INTERACTION 450
47 PERIPHERAL SWELLING 432
48 PYREXIA 420
49 PARAESTHESIA 415
50 WEIGHT INCREASED 413
51 GASTROOESOPHAGEAL REFLUX DISEASE 407
52 BALANCE DISORDER 406
53 COUGH 402
54 DRUG HYPERSENSITIVITY 399
55 ABDOMINAL PAIN 392
56 DECREASED APPETITE 378
57 ABDOMINAL PAIN UPPER 373
58 ALOPECIA 359
59 ENCEPHALOPATHY 341
60 NASOPHARYNGITIS 336
61 CONFUSIONAL STATE 333
62 ABDOMINAL DISCOMFORT 330
63 INJECTION SITE PAIN 328
64 CHEST PAIN 326
65 DEHYDRATION 323
66 BLOOD PRESSURE INCREASED 321
67 SEIZURE 320
68 CONTUSION 315
69 MULTIPLE SCLEROSIS 310
70 MOBILITY DECREASED 305
71 MYALGIA 305
72 PRODUCT USE IN UNAPPROVED INDICATION 305
73 VISION BLURRED 303
74 SINUSITIS 298
75 INFECTION 295
76 LOSS OF CONSCIOUSNESS 295
77 END STAGE RENAL DISEASE 279
78 INFLUENZA 275
79 HYPERHIDROSIS 270
80 MUSCULOSKELETAL STIFFNESS 270
81 VISUAL IMPAIRMENT 266
82 EMOTIONAL DISTRESS 265
83 THERAPY CESSATION 256
84 URTICARIA 254
85 OVERDOSE 250
86 STRESS 249
87 DRUG DOSE OMISSION 246
88 HYPERSENSITIVITY 242
89 ILLNESS 239
90 PSORIASIS 237
91 FLUSHING 235
92 RENAL INJURY 233
93 NEUROPATHY PERIPHERAL 230
94 PALPITATIONS 229
95 ARTHRITIS 228
96 NECK PAIN 228
97 CHILLS 225
98 PRODUCT USE ISSUE 221
99 ANAEMIA 220
100 JOINT SWELLING 220
101 SEPSIS 219
102 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 219
103 HALLUCINATION 218
104 ERYTHEMA 216
105 PRODUCT DOSE OMISSION 216
106 COMA 215
107 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 215
108 SWELLING 214
109 RHEUMATOID ARTHRITIS 212
110 ASTHMA 208
111 HEART RATE INCREASED 208
112 BRONCHITIS 204
113 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 203
114 AMNESIA 199
115 THERAPY INTERRUPTED 197
116 DRUG WITHDRAWAL SYNDROME 196
117 DYSPEPSIA 196
118 BURNING SENSATION 195
119 PNEUMONIA ASPIRATION 194
120 INFLUENZA LIKE ILLNESS 191
121 DYSPHAGIA 190
122 OROPHARYNGEAL PAIN 189
123 OSTEOARTHRITIS 188
124 SYNCOPE 184
125 NEPHROGENIC ANAEMIA 183
126 INCORRECT DOSE ADMINISTERED 179
127 CHEST DISCOMFORT 178
128 DRY MOUTH 177
129 ABDOMINAL DISTENSION 175
130 SLEEP DISORDER 175
131 CEREBROVASCULAR ACCIDENT 174
132 BLOOD GLUCOSE INCREASED 173
133 NEURALGIA 173
134 MUSCLE SPASTICITY 172
135 OSTEOPOROSIS 170
136 HOSPITALISATION 169
137 INTENTIONAL PRODUCT MISUSE 167
138 WITHDRAWAL SYNDROME 167
139 OEDEMA PERIPHERAL 166
140 IMPAIRED GASTRIC EMPTYING 163
141 MYOCARDIAL INFARCTION 162
142 WHITE BLOOD CELL COUNT DECREASED 162
143 HOT FLUSH 161
144 BLOOD PRESSURE DECREASED 159
145 INTENTIONAL PRODUCT USE ISSUE 159
146 RENAL IMPAIRMENT 157
147 PRODUCT QUALITY ISSUE 156
148 INTERVERTEBRAL DISC PROTRUSION 155
149 TACHYCARDIA 155
150 SUICIDAL IDEATION 153
151 COGNITIVE DISORDER 152
152 ANHEDONIA 151
153 NEPHROLITHIASIS 150
154 THROMBOSIS 148
155 DISTURBANCE IN ATTENTION 144
156 CARDIO-RESPIRATORY ARREST 142
157 UPPER RESPIRATORY TRACT INFECTION 142
158 INJECTION SITE ERYTHEMA 141
159 CARDIAC ARREST 140
160 HERPES ZOSTER 140
161 PULMONARY EMBOLISM 140
162 SPEECH DISORDER 140
163 SUSPECTED SUICIDE 139
164 GAIT INABILITY 138
165 CELLULITIS 137
166 CYSTITIS 137
167 HEPATIC ENZYME INCREASED 137
168 INJECTION SITE BRUISING 137
169 FIBROMYALGIA 135
170 ROAD TRAFFIC ACCIDENT 134
171 DRUG DEPENDENCE 133
172 BRADYCARDIA 132
173 RHINORRHOEA 132
174 FEELING HOT 130
175 SURGERY 130
176 DYSSTASIA 127
177 DYSARTHRIA 126
178 HEAD INJURY 126
179 ADVERSE DRUG REACTION 125
180 DRY SKIN 125
181 PSORIATIC ARTHROPATHY 125
182 VERTIGO 125
183 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 123
184 THERAPEUTIC RESPONSE UNEXPECTED 123
185 UNEVALUABLE EVENT 123
186 GASTROINTESTINAL DISORDER 121
187 AGITATION 120
188 REBOUND ACID HYPERSECRETION 120
189 URINARY INCONTINENCE 119
190 ARTHROPATHY 118
191 DISCOMFORT 118
192 INJECTION SITE REACTION 117
193 DIABETES MELLITUS 115
194 BONE PAIN 114
195 DEVICE ISSUE 113
196 INFUSION RELATED REACTION 113
197 CARDIAC FAILURE CONGESTIVE 112
198 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 112
199 SEROTONIN SYNDROME 112
200 TINNITUS 112
201 HAEMORRHAGE 111
202 OXYGEN SATURATION DECREASED 111
203 DYSGEUSIA 108
204 EYE PAIN 107
205 MUSCULOSKELETAL PAIN 107
206 HYPERPARATHYROIDISM SECONDARY 106
207 LETHARGY 106
208 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 105
209 WHEEZING 104
210 BLOOD CHOLESTEROL INCREASED 103
211 MOVEMENT DISORDER 102
212 DYSPHONIA 101
213 NASAL CONGESTION 101
214 STOMATITIS 101
215 UNDERDOSE 101
216 BLOOD POTASSIUM DECREASED 100
217 ATRIAL FIBRILLATION 99
218 SLEEP APNOEA SYNDROME 99
219 CARDIAC DISORDER 98
220 DYSURIA 98
221 HAEMOGLOBIN DECREASED 98
222 GASTROINTESTINAL HAEMORRHAGE 97
223 SKIN EXFOLIATION 97
224 ANKLE FRACTURE 95
225 DEPRESSED MOOD 95
226 FLATULENCE 95
227 BLISTER 94
228 DEEP VEIN THROMBOSIS 94
229 DYSKINESIA 94
230 HEART RATE DECREASED 93
231 IRRITABILITY 93
232 POLLAKIURIA 93
233 RESPIRATORY ARREST 93
234 DIPLOPIA 92
235 ILL-DEFINED DISORDER 92
236 MENTAL STATUS CHANGES 92
237 TUBULOINTERSTITIAL NEPHRITIS 92
238 LIMB DISCOMFORT 91
239 PRODUCT SUBSTITUTION ISSUE 91
240 CATARACT 90
241 INJECTION SITE HAEMORRHAGE 90
242 MUSCLE TIGHTNESS 90
243 EPISTAXIS 89
244 FLUID RETENTION 89
245 NERVOUSNESS 89
246 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 89
247 THROAT IRRITATION 89
248 INJECTION SITE SWELLING 88
249 INJURY 88
250 NIGHTMARE 88
251 OEDEMA 88
252 SKIN DISCOLOURATION 88
253 DEPRESSED LEVEL OF CONSCIOUSNESS 87
254 PANIC ATTACK 87
255 DISORIENTATION 86
256 GENERAL PHYSICAL HEALTH DETERIORATION 86
257 STAPHYLOCOCCAL INFECTION 86
258 BLADDER DISORDER 85
259 DISEASE PROGRESSION 85
260 FOOT FRACTURE 85
261 INFLAMMATION 85
262 SWELLING FACE 85
263 BONE DENSITY DECREASED 84
264 IMPAIRED HEALING 83
265 INTENTIONAL OVERDOSE 83
266 OSTEOPENIA 83
267 INTESTINAL OBSTRUCTION 82
268 MUSCULOSKELETAL DISORDER 82
269 NIGHT SWEATS 81
270 NO ADVERSE EVENT 81
271 TREATMENT FAILURE 81
272 CRYING 80
273 INTERVERTEBRAL DISC DEGENERATION 80
274 PLATELET COUNT DECREASED 80
275 RESPIRATORY FAILURE 80
276 BACK DISORDER 79
277 INJECTION SITE PRURITUS 79
278 SUICIDE ATTEMPT 79
279 MENTAL DISORDER 78
280 RIB FRACTURE 78
281 SCIATICA 78
282 SEDATION 78
283 SPINAL OPERATION 78
284 LIMB INJURY 76
285 SINUS DISORDER 76
286 CROHN^S DISEASE 75
287 DRUG EFFECT DECREASED 75
288 FUNGAL INFECTION 75
289 PRODUCT ADHESION ISSUE 75
290 RESTLESS LEGS SYNDROME 75
291 BLOOD CREATININE INCREASED 74
292 NERVE COMPRESSION 74
293 VITAMIN D DEFICIENCY 74
294 ALANINE AMINOTRANSFERASE INCREASED 73
295 CARDIAC FAILURE 73
296 JOINT INJURY 73
297 MUSCLE TWITCHING 73
298 THERAPEUTIC PRODUCT EFFECT DECREASED 73
299 URINARY RETENTION 73
300 HYPERSOMNIA 72
301 MENTAL IMPAIRMENT 72
302 THERAPEUTIC RESPONSE SHORTENED 72
303 CENTRAL NERVOUS SYSTEM LESION 71
304 DIVERTICULITIS 71
305 RASH PRURITIC 71
306 ADVERSE EVENT 70
307 DRUG ABUSE 70
308 DRUG INTOLERANCE 70
309 FEELING COLD 70
310 ANGER 69
311 APHASIA 69
312 DRY EYE 69
313 JOINT STIFFNESS 69
314 SPINAL FRACTURE 69
315 HYPOKALAEMIA 68
316 LOWER LIMB FRACTURE 68
317 RENAL DISORDER 67
318 THERAPEUTIC RESPONSE DECREASED 67
319 THERAPY NON-RESPONDER 67
320 CHOLELITHIASIS 65
321 ECONOMIC PROBLEM 65
322 LYMPHOCYTE COUNT DECREASED 65
323 BEDRIDDEN 64
324 DEVICE MALFUNCTION 64
325 GASTRIC DISORDER 64
326 IRRITABLE BOWEL SYNDROME 64
327 NEUTROPENIA 64
328 PRODUCTIVE COUGH 64
329 SPINAL OSTEOARTHRITIS 64
330 ASPARTATE AMINOTRANSFERASE INCREASED 63
331 EYE IRRITATION 63
332 HYPOACUSIS 63
333 PERONEAL NERVE PALSY 63
334 PRODUCT DOSE OMISSION IN ERROR 63
335 SEPTIC SHOCK 63
336 DELIRIUM 62
337 EAR INFECTION 62
338 ELECTROCARDIOGRAM QT PROLONGED 62
339 HALLUCINATION, VISUAL 62
340 HEMIPARESIS 62
341 RECTAL HAEMORRHAGE 62
342 RESPIRATORY TRACT INFECTION 62
343 TREATMENT NONCOMPLIANCE 62
344 UNRESPONSIVE TO STIMULI 62
345 WHITE BLOOD CELL COUNT INCREASED 62
346 ABNORMAL DREAMS 61
347 ACCIDENTAL EXPOSURE TO PRODUCT 61
348 PLEURAL EFFUSION 61
349 PROCEDURAL PAIN 61
350 RENAL TUBULAR NECROSIS 61
351 SKIN BURNING SENSATION 61
352 UPPER LIMB FRACTURE 61
353 EYE DISORDER 60
354 HIP FRACTURE 60
355 PANCREATITIS 60
356 SKIN DISORDER 60
357 TRANSIENT ISCHAEMIC ATTACK 60
358 NEOPLASM MALIGNANT 59
359 HYPOGLYCAEMIA 58
360 IMPAIRED QUALITY OF LIFE 58
361 INJECTION SITE MASS 58
362 LYMPHADENOPATHY 58
363 NERVE INJURY 58
364 ORTHOSTATIC HYPOTENSION 58
365 SEASONAL ALLERGY 58
366 CARPAL TUNNEL SYNDROME 57
367 KIDNEY INFECTION 57
368 METABOLIC ACIDOSIS 57
369 RASH ERYTHEMATOUS 57
370 THROMBOCYTOPENIA 57
371 VIRAL INFECTION 57
372 DRUG-INDUCED LIVER INJURY 56
373 SPINAL PAIN 56
374 ABASIA 55
375 ANAPHYLACTIC REACTION 55
376 KNEE ARTHROPLASTY 55
377 LUNG DISORDER 55
378 RESTLESSNESS 55
379 SPINAL DISORDER 55
380 TYPE 2 DIABETES MELLITUS 55
381 DRUG EFFECT INCOMPLETE 54
382 INTENTIONAL DOSE OMISSION 54
383 SKIN ULCER 54
384 SWOLLEN TONGUE 54
385 FEEDING DISORDER 53
386 HYPOXIA 53
387 PARKINSON^S DISEASE 53
388 COLITIS 52
389 MOOD SWINGS 52
390 ACCIDENTAL OVERDOSE 51
391 BLOOD PRESSURE FLUCTUATION 51
392 DYSPNOEA EXERTIONAL 51
393 HEPATIC STEATOSIS 51
394 LABORATORY TEST ABNORMAL 51
395 LOCALISED INFECTION 51
396 MEDICATION ERROR 51
397 MIDDLE INSOMNIA 51
398 MULTIPLE FRACTURES 51
399 MUSCULOSKELETAL DISCOMFORT 51
400 NERVOUS SYSTEM DISORDER 51
401 PAIN IN JAW 51
402 RASH MACULAR 51
403 TEMPERATURE INTOLERANCE 51
404 ACNE 50
405 BONE DISORDER 50
406 CANDIDA INFECTION 50
407 IMPAIRED WORK ABILITY 50
408 BODY HEIGHT DECREASED 49
409 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 49
410 GOUT 49
411 LIGAMENT SPRAIN 49
412 SYSTEMIC LUPUS ERYTHEMATOSUS 49
413 ACUTE RESPIRATORY FAILURE 48
414 AGGRESSION 48
415 ANAL INCONTINENCE 48
416 BLOOD GLUCOSE DECREASED 48
417 CONTRAINDICATED PRODUCT ADMINISTERED 48
418 FEAR 48
419 FEMUR FRACTURE 48
420 HAEMATURIA 48
421 HYPOKINESIA 48
422 HYPOTHYROIDISM 48
423 INCONTINENCE 48
424 MICTURITION URGENCY 48
425 PRESYNCOPE 48
426 PULMONARY OEDEMA 48
427 ABNORMAL BEHAVIOUR 47
428 CONCUSSION 47
429 EXTRA DOSE ADMINISTERED 47
430 GALLBLADDER DISORDER 47
431 GASTRITIS 47
432 ORAL PAIN 47
433 POST PROCEDURAL COMPLICATION 47
434 WALKING AID USER 47
435 BLOOD PRESSURE ABNORMAL 46
436 DISABILITY 46
437 DRUG LEVEL INCREASED 46
438 EYE SWELLING 46
439 GASTROENTERITIS VIRAL 46
440 HEART RATE IRREGULAR 46
441 SENSORY DISTURBANCE 46
442 BLOOD URINE PRESENT 45
443 BRAIN FOG 45
444 COVID-19 PNEUMONIA 45
445 EXOSTOSIS 45
446 HEAD DISCOMFORT 45
447 LACRIMATION INCREASED 45
448 LIP SWELLING 45
449 POOR QUALITY SLEEP 45
450 PRODUCT STORAGE ERROR 45
451 WOUND 45
452 BACK INJURY 44
453 BLINDNESS 44
454 CLOSTRIDIUM DIFFICILE INFECTION 44
455 EMOTIONAL DISORDER 44
456 HYPOPHAGIA 44
457 LIVER DISORDER 44
458 OSTEONECROSIS 44
459 PRODUCT PHYSICAL ISSUE 44
460 RHABDOMYOLYSIS 44
461 WRIST FRACTURE 44
462 ALTERED STATE OF CONSCIOUSNESS 43
463 APPLICATION SITE ERYTHEMA 43
464 CONVULSION 43
465 ECZEMA 43
466 IMPAIRED DRIVING ABILITY 43
467 OBESITY 43
468 OCULAR HYPERAEMIA 43
469 ORAL HERPES 43
470 DERMATITIS ATOPIC 42
471 DISEASE RECURRENCE 42
472 HIATUS HERNIA 42
473 INSURANCE ISSUE 42
474 MATERNAL EXPOSURE DURING PREGNANCY 42
475 PALLOR 42
476 QUALITY OF LIFE DECREASED 42
477 RESPIRATORY DISORDER 42
478 ROTATOR CUFF SYNDROME 42
479 SKIN LESION 42
480 BLOOD SODIUM DECREASED 41
481 BREAST CANCER 41
482 HAEMATOCHEZIA 41
483 HERNIA 41
484 JOINT DISLOCATION 41
485 JOINT RANGE OF MOTION DECREASED 41
486 DEAFNESS 40
487 DEVICE DISLOCATION 40
488 EATING DISORDER 40
489 ERUCTATION 40
490 IMMUNODEFICIENCY 40
491 OPTIC NEURITIS 40
492 PULMONARY MASS 40
493 RED BLOOD CELL COUNT DECREASED 40
494 BLOOD IRON DECREASED 39
495 GLAUCOMA 39
496 HAEMOPTYSIS 39
497 INJECTION SITE RASH 39
498 MOTOR DYSFUNCTION 39
499 PRODUCT PRESCRIBING ERROR 39
500 THINKING ABNORMAL 39
501 TOOTH LOSS 39
502 BODY TEMPERATURE INCREASED 38
503 FEELING JITTERY 38
504 LIVER FUNCTION TEST ABNORMAL 38
505 MUSCLE STRAIN 38
506 POST-TRAUMATIC STRESS DISORDER 38
507 RETCHING 38
508 TOOTHACHE 38
509 TOXIC ENCEPHALOPATHY 38
510 COORDINATION ABNORMAL 37
511 DEVICE RELATED INFECTION 37
512 INJECTION SITE URTICARIA 37
513 SKIN LACERATION 37
514 TOOTH FRACTURE 37
515 TOOTH INFECTION 37
516 CHOKING 36
517 CYST 36
518 GENERALISED TONIC-CLONIC SEIZURE 36
519 HEPATIC FAILURE 36
520 HIP ARTHROPLASTY 36
521 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 36
522 PRESCRIBED UNDERDOSE 36
523 TASTE DISORDER 36
524 THROAT TIGHTNESS 36
525 UROSEPSIS 36
526 WHEELCHAIR USER 36
527 ACTIVITIES OF DAILY LIVING IMPAIRED 35
528 ACUTE MYOCARDIAL INFARCTION 35
529 ARRHYTHMIA 35
530 EAR PAIN 35
531 EPILEPSY 35
532 FRACTURE 35
533 GASTRIC ULCER 35
534 GRIP STRENGTH DECREASED 35
535 HEREDITARY ANGIOEDEMA 35
536 HYPERKALAEMIA 35
537 INFUSION SITE PAIN 35
538 MOOD ALTERED 35
539 SCOLIOSIS 35
540 SKIN HAEMORRHAGE 35
541 SNEEZING 35
542 APHONIA 34
543 BLOOD ALKALINE PHOSPHATASE INCREASED 34
544 DRUG DOSE OMISSION BY DEVICE 34
545 INITIAL INSOMNIA 34
546 MALIGNANT NEOPLASM PROGRESSION 34
547 NEPHROPATHY 34
548 PHARYNGEAL SWELLING 34
549 RESPIRATORY TRACT CONGESTION 34
550 SCAR 34
551 SKIN IRRITATION 34
552 SPINAL COMPRESSION FRACTURE 34
553 THIRST 34
554 ANKYLOSING SPONDYLITIS 33
555 APPLICATION SITE PAIN 33
556 BASAL CELL CARCINOMA 33
557 DEMENTIA 33
558 DEVICE LEAKAGE 33
559 EXPIRED PRODUCT ADMINISTERED 33
560 HYPERLIPIDAEMIA 33
561 POST PROCEDURAL INFECTION 33
562 PRE-EXISTING CONDITION IMPROVED 33
563 PRESCRIBED OVERDOSE 33
564 PSYCHOTIC DISORDER 33
565 SKIN INFECTION 33
566 SPINAL STENOSIS 33
567 TORSADE DE POINTES 33
568 TROPONIN INCREASED 33
569 VAGINAL HAEMORRHAGE 33
570 VITAMIN D DECREASED 33
571 WEIGHT FLUCTUATION 33
572 AGEUSIA 32
573 BACTERIAL INFECTION 32
574 DECREASED INTEREST 32
575 EYE PRURITUS 32
576 FAECES DISCOLOURED 32
577 FOETAL EXPOSURE DURING PREGNANCY 32
578 FULL BLOOD COUNT DECREASED 32
579 LEUKOPENIA 32
580 MUSCULOSKELETAL CHEST PAIN 32
581 PARALYSIS 32
582 CEREBRAL DISORDER 31
583 COLD SWEAT 31
584 COLITIS ULCERATIVE 31
585 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 31
586 FEELING DRUNK 31
587 GASTROINTESTINAL HYPOMOTILITY 31
588 HAEMORRHOIDS 31
589 HYPERGLYCAEMIA 31
590 INJECTION SITE WARMTH 31
591 LEUKOCYTOSIS 31
592 PLASMA CELL MYELOMA 31
593 PRODUCT ADMINISTRATION INTERRUPTED 31
594 RESPIRATORY DISTRESS 31
595 SEXUAL DYSFUNCTION 31
596 SHOCK 31
597 SINUS BRADYCARDIA 31
598 SINUS TACHYCARDIA 31
599 ATAXIA 30
600 BLOOD MAGNESIUM DECREASED 30
601 GAMMA-GLUTAMYLTRANSFERASE INCREASED 30
602 NEEDLE ISSUE 30
603 OSTEOMYELITIS 30
604 PANCYTOPENIA 30
605 PULMONARY THROMBOSIS 30
606 SLUGGISHNESS 30
607 TENDERNESS 30
608 TRANSAMINASES INCREASED 30
609 DECUBITUS ULCER 29
610 FEBRILE NEUTROPENIA 29
611 HAND FRACTURE 29
612 HYPERTONIA 29
613 INCORRECT PRODUCT ADMINISTRATION DURATION 29
614 INCREASED TENDENCY TO BRUISE 29
615 INTERVERTEBRAL DISC DISORDER 29
616 LUMBAR SPINAL STENOSIS 29
617 MALNUTRITION 29
618 PARANOIA 29
619 PHOTOPHOBIA 29
620 PRODUCT DISPENSING ERROR 29
621 SARS-COV-2 TEST POSITIVE 29
622 SENSORY LOSS 29
623 SINUS CONGESTION 29
624 SKIN FISSURES 29
625 TARDIVE DYSKINESIA 29
626 ABDOMINAL PAIN LOWER 28
627 APPLICATION SITE PRURITUS 28
628 ASPIRATION 28
629 BLOOD UREA INCREASED 28
630 BURSITIS 28
631 DENTAL CARIES 28
632 DERMATITIS CONTACT 28
633 FRUSTRATION TOLERANCE DECREASED 28
634 GASTROINTESTINAL PAIN 28
635 GLYCOSYLATED HAEMOGLOBIN INCREASED 28
636 HAIR TEXTURE ABNORMAL 28
637 HYSTERECTOMY 28
638 IMMUNE SYSTEM DISORDER 28
639 INCORRECT DRUG ADMINISTRATION DURATION 28
640 INFUSION SITE ERYTHEMA 28
641 INFUSION SITE SWELLING 28
642 MULTIPLE ALLERGIES 28
643 PAIN OF SKIN 28
644 SKIN ABRASION 28
645 TACHYPNOEA 28
646 BIPOLAR DISORDER 27
647 DELUSION 27
648 HAEMATOMA 27
649 HAIR COLOUR CHANGES 27
650 HYPOTONIA 27
651 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27
652 ORAL CANDIDIASIS 27
653 PHARYNGITIS STREPTOCOCCAL 27
654 SPINAL FUSION SURGERY 27
655 TIBIA FRACTURE 27
656 TOOTH DISORDER 27
657 UMBILICAL HERNIA 27
658 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 27
659 ACCIDENT 26
660 ACUTE HEPATIC FAILURE 26
661 AKATHISIA 26
662 CHROMATURIA 26
663 DEVICE DIFFICULT TO USE 26
664 DYSTONIA 26
665 EUPHORIC MOOD 26
666 FACIAL PAIN 26
667 HYPOAESTHESIA ORAL 26
668 ILEUS 26
669 LACERATION 26
670 LUNG NEOPLASM MALIGNANT 26
671 LYMPHOPENIA 26
672 MAJOR DEPRESSION 26
673 MENISCUS INJURY 26
674 NODULE 26
675 ORAL DISCOMFORT 26
676 PRURITUS GENERALISED 26
677 TENDON RUPTURE 26
678 VENTRICULAR TACHYCARDIA 26
679 VITREOUS FLOATERS 26
680 ACCIDENTAL DEATH 25
681 BLOOD BILIRUBIN INCREASED 25
682 DIABETIC KETOACIDOSIS 25
683 DYSGRAPHIA 25
684 FACIAL PARALYSIS 25
685 FOOT OPERATION 25
686 HOSPICE CARE 25
687 INTERNAL HAEMORRHAGE 25
688 INTRACRANIAL ANEURYSM 25
689 MACULOPATHY 25
690 MASS 25
691 MIOSIS 25
692 NOCTURIA 25
693 PRODUCT AVAILABILITY ISSUE 25
694 PROTEINURIA 25
695 SOMNAMBULISM 25
696 TENDONITIS 25
697 ULCER 25
698 VISUAL ACUITY REDUCED 25
699 ANGIOEDEMA 24
700 APNOEA 24
701 BLOOD GLUCOSE ABNORMAL 24
702 BLOOD TRIGLYCERIDES INCREASED 24
703 CEREBRAL HAEMORRHAGE 24
704 CHOLECYSTITIS 24
705 DECREASED ACTIVITY 24
706 DEVICE BREAKAGE 24
707 DIZZINESS POSTURAL 24
708 FORMICATION 24
709 FREQUENT BOWEL MOVEMENTS 24
710 HEPATIC FUNCTION ABNORMAL 24
711 INCREASED APPETITE 24
712 LIVER FUNCTION TEST INCREASED 24
713 MADAROSIS 24
714 PELVIC PAIN 24
715 POISONING 24
716 PRODUCT USE COMPLAINT 24
717 PSYCHOMOTOR HYPERACTIVITY 24
718 SCAB 24
719 SPINAL COLUMN STENOSIS 24
720 THYROID DISORDER 24
721 ANGINA PECTORIS 23
722 BENIGN PROSTATIC HYPERPLASIA 23
723 CERVICAL VERTEBRAL FRACTURE 23
724 EYE MOVEMENT DISORDER 23
725 FIBULA FRACTURE 23
726 HAEMATEMESIS 23
727 HALLUCINATION, AUDITORY 23
728 HYPONATRAEMIA 23
729 KNEE OPERATION 23
730 LOCAL SWELLING 23
731 MUSCLE ATROPHY 23
732 PERICARDIAL EFFUSION 23
733 PERIPHERAL COLDNESS 23
734 PSYCHOLOGICAL TRAUMA 23
735 RESPIRATORY DEPRESSION 23
736 TENDON PAIN 23
737 TOOTH ABSCESS 23
738 TOOTH INJURY 23
739 VITAMIN B12 DEFICIENCY 23
740 ARTHROPOD BITE 22
741 AUTOIMMUNE DISORDER 22
742 BLINDNESS UNILATERAL 22
743 BLOOD CREATINE PHOSPHOKINASE INCREASED 22
744 BLOOD POTASSIUM INCREASED 22
745 BRAIN INJURY 22
746 CARDIOVASCULAR DISORDER 22
747 COMPLICATION ASSOCIATED WITH DEVICE 22
748 CORONARY ARTERY DISEASE 22
749 DECREASED IMMUNE RESPONSIVENESS 22
750 DEVICE OCCLUSION 22
751 FEELING OF BODY TEMPERATURE CHANGE 22
752 FOOT DEFORMITY 22
753 HAIR DISORDER 22
754 HEPATIC CIRRHOSIS 22
755 HYPERTHYROIDISM 22
756 INTERNATIONAL NORMALISED RATIO INCREASED 22
757 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 22
758 LARGE INTESTINE POLYP 22
759 MUSCLE DISORDER 22
760 NEPHROTIC SYNDROME 22
761 NEUTROPHIL COUNT INCREASED 22
762 PANCREATITIS ACUTE 22
763 PARAESTHESIA ORAL 22
764 PNEUMOTHORAX 22
765 RENAL FAILURE ACUTE 22
766 SECRETION DISCHARGE 22
767 SKIN CANCER 22
768 SMALL INTESTINAL OBSTRUCTION 22
769 STRESS CARDIOMYOPATHY 22
770 WOUND INFECTION 22
771 ABSCESS 21
772 BONE LOSS 21
773 CHOLECYSTECTOMY 21
774 FLANK PAIN 21
775 GINGIVAL BLEEDING 21
776 GLOSSODYNIA 21
777 HAEMATOCRIT DECREASED 21
778 HEPATOTOXICITY 21
779 HUNGER 21
780 INCORRECT DOSE ADMINISTERED BY DEVICE 21
781 MANIA 21
782 POOR VENOUS ACCESS 21
783 PULMONARY HYPERTENSION 21
784 THERAPY CHANGE 21
785 BLOOD CALCIUM INCREASED 20
786 CARDIOMYOPATHY 20
787 CORONARY ARTERY OCCLUSION 20
788 DERMAL CYST 20
789 DERMATITIS 20
790 DIVERTICULUM 20
791 DRUG EFFECT LESS THAN EXPECTED 20
792 EXTRAPYRAMIDAL DISORDER 20
793 GASTROENTERITIS 20
794 GLOMERULAR FILTRATION RATE DECREASED 20
795 GROIN PAIN 20
796 HIP SURGERY 20
797 HOMICIDAL IDEATION 20
798 HYPERAESTHESIA 20
799 INJECTION SITE INDURATION 20
800 MUSCLE RIGIDITY 20
801 NEUTROPHIL COUNT DECREASED 20
802 PARKINSONISM 20
803 PETECHIAE 20
804 PRODUCT PRESCRIBING ISSUE 20
805 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 20
806 RENAL CYST 20
807 SHOULDER OPERATION 20
808 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 20
809 SPONDYLITIS 20
810 SYNOVIAL CYST 20
811 TOOTH EXTRACTION 20
812 TRIGEMINAL NEURALGIA 20
813 ADRENAL INSUFFICIENCY 19
814 BLOOD PRESSURE SYSTOLIC INCREASED 19
815 CARDIOGENIC SHOCK 19
816 CARDIOMEGALY 19
817 CLOSTRIDIUM DIFFICILE COLITIS 19
818 COLON CANCER 19
819 ELECTROLYTE IMBALANCE 19
820 ERECTILE DYSFUNCTION 19
821 ESSENTIAL HYPERTENSION 19
822 EYE DISCHARGE 19
823 FAILURE TO SUSPEND MEDICATION 19
824 FUNGAL SKIN INFECTION 19
825 GASTRIC CANCER 19
826 HEPATITIS 19
827 HYPERTHERMIA 19
828 HYPERTRANSAMINASAEMIA 19
829 INTERSTITIAL LUNG DISEASE 19
830 LACTIC ACIDOSIS 19
831 LOW DENSITY LIPOPROTEIN INCREASED 19
832 MYOCLONUS 19
833 NECK SURGERY 19
834 RESPIRATION ABNORMAL 19
835 SICKLE CELL ANAEMIA WITH CRISIS 19
836 SKIN WARM 19
837 STIFF PERSON SYNDROME 19
838 WRONG PATIENT RECEIVED PRODUCT 19
839 ABNORMAL FAECES 18
840 ANOSMIA 18
841 APATHY 18
842 ASCITES 18
843 AUTONOMIC NERVOUS SYSTEM IMBALANCE 18
844 B-LYMPHOCYTE COUNT DECREASED 18
845 BLOOD COUNT ABNORMAL 18
846 BLOOD PRESSURE DIASTOLIC DECREASED 18
847 BONE DEMINERALISATION 18
848 CEREBRAL INFARCTION 18
849 EAR DISCOMFORT 18
850 EYE INFECTION 18
851 EYELID PTOSIS 18
852 GASTROINTESTINAL MOTILITY DISORDER 18
853 HYPOTHERMIA 18
854 INFUSION SITE PRURITUS 18
855 JOINT EFFUSION 18
856 LARYNGITIS 18
857 LIVER INJURY 18
858 LYMPHOEDEMA 18
859 NEUROGENIC BLADDER 18
860 PHARYNGITIS 18
861 PRODUCT ADMINISTRATION ERROR 18
862 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18
863 TONGUE DISCOMFORT 18
864 ADVERSE REACTION 17
865 ANAL FISTULA 17
866 CERVICAL SPINAL STENOSIS 17
867 CONCOMITANT DISEASE AGGRAVATED 17
868 DRUG SCREEN NEGATIVE 17
869 DRUG SCREEN POSITIVE 17
870 ELECTROCARDIOGRAM ABNORMAL 17
871 ESCHERICHIA URINARY TRACT INFECTION 17
872 EXPOSURE VIA SKIN CONTACT 17
873 EYE HAEMORRHAGE 17
874 FOOD POISONING 17
875 FUNCTIONAL GASTROINTESTINAL DISORDER 17
876 GASTROINTESTINAL INFECTION 17
877 HEMIPLEGIA 17
878 HEPATOMEGALY 17
879 HYPOMAGNESAEMIA 17
880 IMMUNOSUPPRESSION 17
881 INABILITY TO AFFORD MEDICATION 17
882 INCOHERENT 17
883 INFUSION SITE BRUISING 17
884 LOWER RESPIRATORY TRACT INFECTION 17
885 LYMPHOCYTE COUNT INCREASED 17
886 ORAL MUCOSAL BLISTERING 17
887 PARAPARESIS 17
888 PELVIC FRACTURE 17
889 PHARYNGEAL OEDEMA 17
890 PLATELET COUNT INCREASED 17
891 PRODUCT COMPLAINT 17
892 PRODUCT SOLUBILITY ABNORMAL 17
893 PSYCHIATRIC SYMPTOM 17
894 PULMONARY FIBROSIS 17
895 RED BLOOD CELL SEDIMENTATION RATE INCREASED 17
896 SCRATCH 17
897 SENSITIVITY TO WEATHER CHANGE 17
898 SUPRAVENTRICULAR TACHYCARDIA 17
899 ATELECTASIS 16
900 DEVICE FAILURE 16
901 DRUG TOLERANCE 16
902 DRY AGE-RELATED MACULAR DEGENERATION 16
903 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 16
904 ESCHERICHIA INFECTION 16
905 GLUCOSE TOLERANCE IMPAIRED 16
906 HUMERUS FRACTURE 16
907 INFLAMMATORY MARKER INCREASED 16
908 MELANOCYTIC NAEVUS 16
909 MONOPLEGIA 16
910 MUSCLE RUPTURE 16
911 NECK INJURY 16
912 NEOPLASM PROGRESSION 16
913 ONYCHOCLASIS 16
914 PAPULE 16
915 PARANASAL SINUS DISCOMFORT 16
916 PHOTOSENSITIVITY REACTION 16
917 POLYP 16
918 POSTOPERATIVE WOUND INFECTION 16
919 RASH PAPULAR 16
920 SJOGREN^S SYNDROME 16
921 THYROID MASS 16
922 TRANSFUSION 16
923 VARICOSE VEIN 16
924 WRONG TECHNIQUE IN DRUG USAGE PROCESS 16
925 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 15
926 ACUTE RESPIRATORY DISTRESS SYNDROME 15
927 AFFECTIVE DISORDER 15
928 ANAL HAEMORRHAGE 15
929 ARTHRITIS INFECTIVE 15
930 BLOOD CHOLESTEROL ABNORMAL 15
931 BLOOD PRESSURE DIASTOLIC ABNORMAL 15
932 BLOOD PRESSURE SYSTOLIC ABNORMAL 15
933 BLOOD TEST ABNORMAL 15
934 BOWEL MOVEMENT IRREGULARITY 15
935 CLONUS 15
936 COAGULOPATHY 15
937 DIABETIC NEUROPATHY 15
938 DRUG DISPENSING ERROR 15
939 DRY THROAT 15
940 EMPHYSEMA 15
941 GASTROINTESTINAL INFLAMMATION 15
942 GINGIVAL PAIN 15
943 HEART RATE ABNORMAL 15
944 HYPERTONIC BLADDER 15
945 INADEQUATE ANALGESIA 15
946 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15
947 INFECTED DERMAL CYST 15
948 INFUSION SITE EXTRAVASATION 15
949 LOSS OF CONTROL OF LEGS 15
950 LUMBAR RADICULOPATHY 15
951 MACULAR DEGENERATION 15
952 MALIGNANT MELANOMA 15
953 MONOCYTE COUNT INCREASED 15
954 MUSCLE FATIGUE 15
955 MYDRIASIS 15
956 NEUROLEPTIC MALIGNANT SYNDROME 15
957 NO THERAPEUTIC RESPONSE 15
958 OCULAR DISCOMFORT 15
959 OVARIAN CYST 15
960 OVERWEIGHT 15
961 PANCREATIC CARCINOMA 15
962 PERICARDIAL HAEMORRHAGE 15
963 PERITONITIS 15
964 PLEURISY 15
965 PNEUMONITIS 15
966 POST PROCEDURAL HAEMORRHAGE 15
967 PRODUCT TASTE ABNORMAL 15
968 PROGRESSIVE MULTIPLE SCLEROSIS 15
969 RENAL PAIN 15
970 RESPIRATORY RATE DECREASED 15
971 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 15
972 SELF-MEDICATION 15
973 SINUS PAIN 15
974 UHTHOFF^S PHENOMENON 15
975 URINARY HESITATION 15
976 AFFECT LABILITY 14
977 ARTERIOVENOUS FISTULA 14
978 ATRIOVENTRICULAR BLOCK COMPLETE 14
979 AUTOIMMUNE HEPATITIS 14
980 BLEPHAROSPASM 14
981 BLOOD THYROID STIMULATING HORMONE DECREASED 14
982 BREAKTHROUGH PAIN 14
983 BREAST MASS 14
984 BRONCHOSPASM 14
985 C-REACTIVE PROTEIN INCREASED 14
986 CARTILAGE INJURY 14
987 CIRCULATORY COLLAPSE 14
988 COLITIS ISCHAEMIC 14
989 DYSPHEMIA 14
990 EAR PRURITUS 14
991 ENERGY INCREASED 14
992 FACE INJURY 14
993 FURUNCLE 14
994 HEPATITIS ACUTE 14
995 HYPERTENSIVE CRISIS 14
996 HYPOREFLEXIA 14
997 INCORRECT DRUG ADMINISTRATION RATE 14
998 INJURY ASSOCIATED WITH DEVICE 14
999 JC POLYOMAVIRUS TEST POSITIVE 14